Visit DOTmed at RSNA, North Hall B, Booth #6608 -- Ask about Clean Sweep Equipment Auctions

Current Location:
> This Story

starstarstarstarempty star (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

Never Miss a Story

Sign up for email alerts


More Industry Headlines

Are compact, tunable X-ray devices made of graphene the future? May reduce radiation dose and cost associated with current X-ray devices

Dell announces entry into health care monitor market New device is designed to meet IEC 60601-1 standard

Canadian hospital clerk who sold maternity records fined $27,000 — hospital facing $308.4 million suit From 1995 to 2014 she sold at least 14,450 records

Google Glass used to treat blocked coronary artery for first time A more economical option

UnitedHealth scaling back efforts in ACA exchanges May quit them entirely in 2017

Discover Cinematic Rendering technology A talk with Dr. Dorin Comaniciu, vice president of Siemens’ Medical Imaging Technologies

Ingestible device can measure heart and breathing rates from inside the GI tract 'An extremely tiny stethoscope you can swallow'

Philips' app-based ultrasound, Lumify, is available in the U.S. First ultrasound solution offered on a subscription basis

Bundled payments to overhaul lucrative total joint replacement surgery sector The new rule will be initially rolled out in 67 metropolitan areas in April of 2016

Wearable ultrasound glasses take the guesswork out of IV placement A first person account from the halls of MEDICA

Regenerative medicine
to generate sales

Regenerative Medicine to Be a $20 Billion Industry by 2025

by Brendon Nafziger , DOTmed News Associate Editor
Explosive growth over the next decade in the field of regenerative medicine could aid medical device companies looking to develop "delivery systems" for cell therapies, according to an analysis released last week.

The market for technologies that repair the body now stands at $1.6 billion, but could swell to $15-20 billion over the next 15 years, says Arshad Ahmed, partner of Scientia Advisors, a biotech and medical consulting firm, in a global market review.

Story Continues Below Advertisement

Seconds count when treating patients

See How Indiana University Health Methodist Hospital boosts imaging speed when seconds count in the treatment of seriously ill patients. Read more>>>

While regenerative medicine conjures up mad-science images of growing batches of new organs or limbs - or even the infamous mouse with a human ear blooming on its back - the main focus of "regen" in the short-term will be on practical, specific clinical applications, Ahmed tells DOTmed News.

What these therapies might lack in sci-fi glamor, they make up for in potential clinical benefits to patients and time-saving in physicians' workflows.

For instance, currently, half of the revenues of regen comes from spine fusion applications, such as those supplied by Medtronic, says Ahmed.

These involve bone morphogenetic protein, or BMP, genetically modified human proteins that spur bone growth. It's delivered in a sponge or gel, and helps vertebrae fuse back together after certain kinds of spine surgeries.

Ahmed believes that BMP is a good model for future successful regen products, because it makes doctors' "workflow much simpler than the existing standard of care," he says.

BMP is only approved for some kinds of spinal fusion surgeries and a study last year suggested it was associated with a higher rate of complications. Still, Ahmed points out that it has been widely adopted by surgeons, because it has the potential to make "life much easier" by reducing the number of procedures performed in a back surgery.

For surgeries where doctors can use BMP, they can forgo the usual first step of removing a piece of the patient's hip bone, which they then have to grind to a powder and then re-inject into the patient's spinal cage during the surgery, to encourage healing - a role now taken over by BMP.

"The procedure is simpler and it takes less time for surgeons to do it, so they can see more patients," he says.

Patients like it, too, he notes, as they're spared an extra surgical step.


Over the short-term, Ahmed expects much of the new growth to be in peripheral vascular applications, where regen is helping the body repair damage to the vascular system.

One promising treatment possibly not too far from the clinic is being developed by Pervasis.

Continue reading Regenerative Medicine to Be a $20 Billion Industry by 2025...
  Pages: 1 - 2 - 3 >>


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.